Sealed Air Corporation provides food safety and security, and product protection solutions and equipment in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Food and Protective. The Food segment offers integrated packaging materials and automation equipment solutions to provide food safety and shelf life extension, reduce food waste, automate processes, and optimize total cost for food processors in the fresh red meat, smoked and processed meats, poultry, seafood, plant-based, and dairy markets under the CRYOVAC, CRYOVAC Grip & Tear, CRYOVAC Darfresh, Simple Steps, and Optidure brands. This segment sells its solutions directly to customers through its sales, marketing, and customer service personnel. The Protective segment provides foam, inflatable, suspension and retention, temperature assurance packaging solutions to protect goods to e-commerce, consumer goods, pharmaceutical and medical devices, and industrial manufacturing markets under the SEALED AIR, BUBBLE WRAP, AUTOBAG, SEALED AIR, AUTOBAG, Instapak, Korrvu, Kevothermal, and TempGuard brands. This segment sells its solutions through supply distributors, as well as directly to fabricators, original equipment manufacturers, contract manufacturers, logistics partners, and e-commerce/fulfillment operations. Sealed Air Corporation was incorporated in 1960 and is headquartered in Charlotte, North Carolina.

Sealed Air Corporation

Cymed MicroSkin manufactures and distributes ostomy pouching systems featuring MicroSkin adhesives, which are transparent, hypoallergenic polyurethane films designed for comfort and security in ostomy care.

Cymed MicroSkin

Dr. Starck Unternehmensgruppe is involved in building and environmental technology, insulation technology, and pipeline construction. The company provides a comprehensive range of services for private, public, commercial, and industrial projects.

Dr. Starck Unternehmensgruppe

SEE is a company that provides packaging materials, solutions, and services. The company has expanded beyond packaging materials to offer solutions and services for its customers.

Metric
Company Name	Sealed Air Corporation	Cymed MicroSkin	Dr. Starck Unternehmensgruppe
Symbol	SEE
MSH ID	COM:SEALEDAIR	COM:CYMEDOSTOMY	DE:DR-STARCK
Market	STOCKS	PRIVATE	PRIVATE
Sector	Consumer Cyclical	Healthcare & Health Services	Commercial & Professional Services
Industry	Packaging & Containers	Medical Devices	Construction
Country	US	US	DE
Stage
Employee Count	17K
Website	sealedair.com	cymedostomy.com	dr-starck.de
LinkedIn
Founders

Metric
Market Cap	5.04B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	5.49B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.57B
EBITDA	1.11B
Operating Income	878.90M
Net Income	341.60M
EPS	2.35
Diluted EPS	2.34
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.30
Operating Profit Margin	0.15
EBITDA Margin	0.20
Net Profit Margin	0.07
Return on Equity	0.80
Return on Assets	0.05
Return on Capital Employed	0.14

COM:SEALEDAIR

SEE

Last Close

35.53

22/11 21:00

Market Cap

5.04B

Beta: -

Volume Today

751.74K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	16.18
P/B Ratio	12.36
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.06
EV Multiple	1.46

Metric
Days Sales Outstanding	40.53
Days Payables Outstanding	70.61
Days Inventory Outstanding	76.44
Operating Cycle	120.70
Cash Conversion Cycle	41.40
Asset Turnover	0.76

Metric
Operating Cash Flow	516.20M
Free Cash Flow	272M
Cash Flow to Debt	0.18
Operating Cash Flow/Sales	0.15
Free Cash Flow Yield	0.05

Metric
Cash & Equivalents	346.10M
Accounts Receivable	73.40M
Inventory	774.30M
Goodwill	2.89B
Debt to Capitalization	0.90
Debt to Assets	0.67
Current Ratio	1.23
Quick Ratio	0.80

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	-0.00
R&D to Revenue
SG&A to Revenue